Johnson & Johnson (JNJ) EV to CFO (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly EV to CFO came in at 68.82 in Q2 2026, down 23.35% year-over-year from 89.78 in Q2 2025, and down 68.93% quarter-over-quarter from 221.47 in Q1 2026.
Analysis
Johnson & Johnson (JNJ) EV to CFO (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed EV to CFO across 18 years of filings, most recently posting 68.82 for Q2 2026.
- In Q2 2026, EV to CFO fell 23.35% year-over-year to 68.82; the TTM figure through Jun 2026 stood at 21.48 (up 42.05% YoY), while the FY2025 annual figure was 19.58, up 46.32% from the prior year.
- EV to CFO came in at 68.82 for Q2 2026 at Johnson & Johnson, down from 221.47 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 221.47 in Q1 2026 to a low of 45.1 in Q4 2023.
- Average EV to CFO over 5 years is 85.17, with a median of 76.95 recorded in 2025.
- Year-over-year, EV to CFO plunged 63.78% in 2023 and surged 160.31% in 2026.
- Over 5 years, EV to CFO stood at 110.2 in 2022, then tumbled by 59.08% to 45.1 in 2023, then grew by 3.1% to 46.5 in 2024, then soared by 41.31% to 65.71 in 2025, then advanced by 4.73% to 68.82 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 68.82 in Q2 2026, 221.47 in Q1 2026, and 65.71 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 68.82 |
| Mar 29, 2026 | 221.47 |
| Dec 28, 2025 | 65.71 |
| Sep 28, 2025 | 45.20 |
| Jun 29, 2025 | 89.78 |
| Mar 30, 2025 | 85.08 |
| Dec 29, 2024 | 46.50 |
| Sep 29, 2024 | 46.08 |
| Jun 30, 2024 | 57.94 |
| Mar 31, 2024 | 96.94 |
| Dec 31, 2023 | 45.10 |
| Oct 1, 2023 | 46.93 |
| Jul 2, 2023 | 96.35 |
| Apr 2, 2023 | 116.12 |
| Jan 1, 2023 | 124.51 |
| Apr 3, 2022 | 110.20 |
| Oct 3, 2021 | 47.22 |
| Jul 4, 2021 | 78.95 |
| Apr 4, 2021 | 99.21 |
| Jan 3, 2021 | 46.57 |